Bone Marrow TransplantationTransplantation, AutologousTransplantation, HomologousBone MarrowHematopoietic Stem Cell TransplantationBone Marrow CellsGraft vs Host DiseaseTransplantation ConditioningLiver TransplantationWhole-Body IrradiationGraft SurvivalKidney TransplantationStem Cell TransplantationBone Marrow PurgingBone and BonesTransplantation ChimeraBusulfanLeukemiaTissue DonorsAnemia, AplasticHematopoietic Stem CellsCombined Modality TherapyCyclophosphamideTreatment OutcomeMultiple MyelomaRecurrenceHistocompatibility TestingHeart TransplantationLymphoma, Non-HodgkinMelphalanTransplantation, IsogeneicRemission InductionHistocompatibilityLung TransplantationHematologic NeoplasmsGraft RejectionImmunosuppressive AgentsHematopoiesisPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell MobilizationTime FactorsCarmustineTransplantation ImmunologyCell TransplantationLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsSurvival AnalysisRetrospective StudiesBone Marrow DiseasesAntigens, CD34Granulocyte Colony-Stimulating FactorOrgan TransplantationMice, Inbred C57BLSalvage TherapyDisease-Free SurvivalImmunosuppressionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraEtoposideSurvival RateCytarabineGraft vs Tumor EffectColony-Forming Units AssayFollow-Up StudiesMyelodysplastic SyndromesHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone Marrow ExaminationLeukemia, MyeloidAcute DiseaseGraft vs Host ReactionLymphocyte DepletionPancreas TransplantationT-LymphocytesIslets of Langerhans TransplantationHLA AntigensBone RemodelingLeukocyte TransfusionBone Marrow NeoplasmsCyclosporineTransplantationLymphomaLeukapheresisCell DifferentiationSevere Combined ImmunodeficiencyCells, CulturedPrognosisChimeraActuarial AnalysisCord Blood Stem Cell TransplantationLymphocyte TransfusionHematologic DiseasesFlow CytometryCell SeparationLiving DonorsNeoplasm, ResidualCytomegalovirus InfectionsTransplantation ToleranceVincristine